Filing Details

Accession Number:
0001209191-19-046976
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-21 16:16:06
Reporting Period:
2019-08-19
Accepted Time:
2019-08-21 16:16:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339469 Chiasma Inc CHMA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1586687 Scott Minick C/O Chiasma, Inc.
460 Totten Pond Rd, Suite 530
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-19 4,300 $5.02 81,676 No 4 P Indirect See Footnote
Common Stock Acquisiton 2019-08-20 5,518 $5.33 87,194 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 62,531 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $5.000 to $5.040, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. The amounts set forth in Column 5 of the prior Form 4s filed by the Reporting Person incorrectly included 6,844 shares of Common Stock underlying a warrant beneficially owned by the Reporting Person. The amounts in Column 5 of this Form 4 set forth the number of non-derivative securities beneficially owned by the Reporting Person following the reported transactions.
  3. The securities are directly held by the Minick Family Trust ("MFT"). The Reporting Person is the co-trustee of MFT and disclaims beneficial ownership of all the shares except to the extent of his pecuniary interest, if any, therein.
  4. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $5.310 to $5.358, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.